![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 31, 21588-21593, August 4, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







¶
¶||
¶1
From the
Departments of
Biochemistry,
Pharmacology, and ||Cellular and Structural Biology and the ¶Barshop Center for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, Texas 78229
3-Phosphoinositide-dependent protein kinase-1 (PDK1) mediates phosphorylation and activation of members of the AGC protein kinase family and plays an essential role in insulin signaling and action. However, whether and how PDK1 activity is regulated in cells remains largely uncharacterized. In the present study, we show that PDK1 undergoes insulin-stimulated and phosphatidylinositol 3-kinase-dependent phosphorylation at Ser244 in the activation loop and at a novel site: Ser163 in the hinge region between the two lobes of the kinase domain. Sequence alignment studies revealed that the residue corresponding to Ser163 of PDK1 in all other AGC kinases is glutamate, suggesting that a negative charge at this site may be important for PDK1 function. Replacing Ser163 with a negatively charged residue, glutamate, led to a 2-fold increase in PDK1 activity. Molecular modeling studies suggested that phosphorylated Ser163 may form additional hydrogen bonds with Tyr149 and Gln223. In support of this, mutation of Tyr149 to Ala is sufficient to reduce PDK1 activity. Taken together, our results suggest that PDK1 phosphorylation of Ser163 may provide a mechanism to fine-tune PDK1 activity and function in cells.
Received for publication, January 17, 2006 , and in revised form, May 22, 2006.
* This work was supported by a Research Award from the American Diabetes Association (to F. L.) and an National Institutes of Health Predoctoral Fellowship F31DK068874 (to R. A. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Pharmacology, UTHSCSA, 7703 Floyd Curl Dr., San Antonio, TX 78229. E-mail: liuf{at}uthscsa.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Hu, Y. Qin, G. Bochorishvili, Y. Zhu, L. van Aelst, and J. J. Zhu Ras Signaling Mechanisms Underlying Impaired GluR1-Dependent Plasticity Associated with Fragile X Syndrome J. Neurosci., July 30, 2008; 28(31): 7847 - 7862. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pearn, J. Fisher, A. K. Burnett, and R. L. Darley The role of PKC and PDK1 in monocyte lineage specification by Ras Blood, May 15, 2007; 109(10): 4461 - 4469. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |